Advocacy intelligence hub — real-time data for patient organizations
Centre hospitalier de l'Université de Montréal (CHUM) — PHASE1, PHASE2
University of Calgary — PHASE2
Anne E Ray — NA
Marmara University
Shanghai Yueyang Integrated Medicine Hospital
Ankara Etlik City Hospital
Hiroshima University — NA
Cairo University
Riphah International University — NA
Radboud University Medical Center — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Oculocerebral hypopigmentation syndrome, Cross type news →
Binu V John, MD MPH
Miami VA Healthcare System, Miami, FL
📍 RICHMOND, VA
Tomasz Masior
VectivBio AG
Ulrike Hövelmann, MD
Profil Institut für Stoffwechselforschung GmbH
Mark Matson, M.D.
Prism Research Inc
Rémi Rabasa-Lhoret
Institut de recherches cliniques de Montréal
Muhammad Affan Iqbal, PhD*
Riphah International University
View all Oculocerebral hypopigmentation syndrome, Cross type specialists →